
Cell Bauhaus
Builds software to enable computer aided design of living systems.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | AUD1.7m | Early VC | |
Total Funding | 000k |
Related Content
Cell Bauhaus operates in the synthetic biology market, offering a virtual cell design platform that enables clients to reprogram cells using a library of standardized biological parts. The company serves industries seeking sustainable solutions by providing a blueprint for biological builds, allowing for faster and more cost-effective product development. Its business model likely involves partnerships and collaborations with organizations aiming to innovate sustainably. Revenue generation may stem from licensing its technology, consulting services, and possibly subscription models for ongoing access to its platform. The company leverages computer-aided design to enhance the efficiency of bringing products to market, addressing pressing global challenges through synthetic biology.
Keywords: synthetic biology, virtual cell design, biological builds, sustainable solutions, genetic constructs, standardized parts, market acceleration, cost-effective, partnerships, blueprint.